(EMAILWIRE.COM, August 24, 2018 ) Browse 86 market data Tables and 38 Figures spread through 140 Pages and in-depth TOC on "Gene Panel Market"
https://www.marketsandmarkets.com/Market-Reports/gene-panel-market-101282859.html
Early buyers will receive 10% customization on this report.

The growth of this market is mainly driven by increasing prevalence of chronic diseases, growing company initiatives (in terms of strategic partnerships, collaborations, and new product launches), and growing adoption of gene panels owing to their benefits.

The gene panels market is segmented by product & service, technique, design, end user, application, and region. By product & service, the market is segmented into test kits and testing services. In 2018, the testing services segment is expected to grow at the highest CAGR during the forecast period.

The high growth of this segment can be attributed to factors such as the increasing focus of market players on providing efficient gene panel services to researchers and the growing number of government funding programs for genomic research.

Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=101282859

Based on technique, the market is segmented into the amplicon-based approach and the hybridization-based approach. The amplicon-based approach segment is expected to grow at the highest CAGR during the forecast period. The use of this technique reduces sequencing costs and turnaround time. These factors are supporting the growth of the amplicon-based approach segment during the forecast period.

Based on design, the market is segmented into predesigned and customized panels. The customized gene panels segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the increasing number of clinical and preclinical research studies and evolving needs of the emerging therapeutic and diagnostic application sectors.

Based on application, the market is segmented into cancer risk assessment, diagnosis of congenital diseases, pharmacogenetics, and other applications. In 2018, the cancer risk assessment segment is expected to account for the largest share of the global gene panels market. This segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the increasing incidence of cancer and growing demand for gene panels in research and diagnostics to understand the genetic variability of cancer.

Based on end user, the market is segmented into research and academic institutes, hospital and diagnostic laboratories, and pharmaceutical and biotechnology companies. The research and academic institutes segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to increasing government funding programs across the globe and the focus of market players on providing efficient gene panels.

Get the Sample Pages@
https://www.marketsandmarkets.com/requestsample.asp?id=101282859

The global gene panels market is dominated by North America, followed by Europe. North America is expected to continue to dominate this market and grow at the highest CAGR during the forecast period. The large share of the North American market can be attributed to factors such as government support for genomics research, the presence of leading NGS providers, growing research on cancer and inherited rare diseases, and increasing number of NGS-based & clinical applications in the region.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com